FindMyKOL
Clinical trialNCT07814495Not, yet, recruitingInterventional

A Human Influenza Transmission Study Using Naturally Infected Community Donors

NCT07814495 is an interventional trial sponsored by Emory University. As of 21 Nov 2026, it is not yet recruiting. It studies Influenza. The registry lists an enrollment of 150 participants at 2 sites in 1 country. The registry lists a start date of 31 Dec 2026 and a primary completion date of 31 Mar 2031. One of its registered investigators has a FindMyKOL profile.

SponsorEmory University →Enrollment150Influenza
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07814495
FieldValue
Registry IDNCT07814495
StatusNot yet recruiting
Study typeInterventional trial
Lead sponsorEmory University
Enrollment150
Registered sites2
Countries1
ConditionsInfluenza
Start31 Dec 2026
Primary completion31 Mar 2031
Study completion31 Mar 2031
Last update posted11 Sept 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether influenza A or B can be transmitted from adults with naturally acquired community influenza infection to healthy adult recipients under controlled inpatient exposure conditions, and to identify donor, recipient, viral, immunologic, behavioral, and environmental factors associated with transmission. This study differs from a traditional influenza CHIM because no challenge stock will be administered. Instead, naturally infected community donors will serve as the source of exposure. This approach is intended to better reflect naturally circulating influenza viruses and naturally infected donors while preserving the safety advantages of inpatient monitoring, defined exposure windows, controlled environmental measurements, and standardized sampling.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Georgia, United States2 sites
  • Emory University Hospital (euh)

    Atlanta

  • Hope Clinic

    Atlanta

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgia: 2 sitesGA2HawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT07814495

Each answer restates registry values shown on this page.

What is NCT07814495?

NCT07814495 is an interventional trial sponsored by Emory University. It studies Influenza.

Is NCT07814495 recruiting?

As of 21 Nov 2026, it is not yet recruiting.

Who leads NCT07814495?

The registry names Nadine Rouphael, MD, MSc (principal investigator, Emory University) as the overall official.

Where does NCT07814495 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT07814495 expected to complete?

The registry lists a primary completion date of 31 Mar 2031 and a study completion date of 31 Mar 2031. The sponsor last updated the record on 11 Sept 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.